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By means of a DNA-cellulose competitive binding assay, we have studied the interaction of the estrogen receptor with genomic fragments of the 
estrogen responsive rabbit uteroglobin gene. The fragments panned from 3255 bp upstream to 1754 bp downstream of the initiation site. Only 
a fragment (-396/+ 8) showed strong affinity for the receptor. Within this fragment a unique palindromic sequence (GGTCAccaTGCCC) was found 
which is very similar to the canonical consensus equence for the estrogen receptor. A synthetic oligonucleotide of that structure specifically com- 
peted for the binding of the receptor to DNA-cellulose. 
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1. INTRODUCTION 
Steroid hormones mediate their main biological re- 
sponse by binding to specific receptor proteins that, in 
turn, interact with short regions of the regulated genes 
and modulate their transcription [l]. These DNA 
regions, known as HRE, have been characterized by 
several methods and shown to contain specific consen- 
sus sequences for the hormonal receptors [2]. 
The steroid hormone regulation of the rabbit utero- 
globin gene has received considerable attention, since 
this gene is subjected to tissue-specific regulation by 
several steroid hormones. Thus, uteroglobin is induced 
by progesterone and estradiol in uterus [3], by glucocor- 
ticoids in lung [4,5], by androgens in the epididymis [6] 
and by estrogens in the oviduct [7]. While HREs for 
glucocorticoids and progesterone have been observed in 
the uteroglobin gene [8], no data on the existence and 
localization of a HRE for estrogens are so far available. 
These data are important for further studies on the reg- 
ulation of the expression of this gene. Here, we show 
evidence for an ER binding site near the promoter of 
the uteroglobin gene. 
2. MATERIALS AND METHODS 
[3H]Estradiol (112 Ci/mmol) was obtained from Amersham Inter- 
national. DNA-cellulose (9 mg of DNA/g) was prepared as previous- 
Correspondence address: A. Nieto, Centro de Biologia Molecular, 
Universidad Autonoma de Madrid, Cantoblanco, 28049 Madrid, 
Spain 
Abbreviations: HRE, hormone regulatory element; ER, estrogen 
receptor 
ly described [9]. The pUG5 clone, containing 5 kb of the uteroglobin 
gene [8], was a gift from Dr Beato, Marburg University, FRG. The 
DNA was digested with the appropriate restriction enzyme and the 
fragments were either subcloned in pUCl8 or separated by electro- 
phoresis on agarose gels. 
2.1. Preparation of the ER 
Rabbit uterus was homogenized in 4 vols (w/v) of DTE (2 mM di- 
thiothreitol, 1 mM EDTA, 40 mM Tris-HCI, pH 7.4). After centri- 
fugation for 1 h at 150 000 x g, the supernatant was brought to 30% 
of (NH&S04 saturation, centrifuged for 15 min at 20000 x g and the 
pellet was dissolved in DTE. This precipitation step served both to 
partially purify the receptor and to convert it into a DNA-binding 
form [lo]. The receptor preparation was labelled by incubation for 
2 h with 10 nM [‘Hlestradiol and the free hormone was absorbed 
with dextran-coated charcoal [lo]. All of the above operations were 
carried out at 0-4°C. 
2.2. DNA-cellulose binding assay 
This was performed essentially as described [l I]. Briefly, 
0.3-0.5 mg of DNA-cellulose was incubated at 0°C with the receptor 
preparation, with or without competing DNA. The binding buffer 
was DTE containing 10% glycerol and 50 mM NaCl and the final vol- 
ume was 150~1. After 45 min, the suspension was centrifuged, the 
pellet washed with binding buffer and its radioactivity was measured. 
3. RESULTS 
The schematic structure and the restriction fragments 
of the genomic clone pUG5 are shown in Fig.1. In a 
first approach, 4 large fragments were tested in the 
competitive binding assay. In this assay, useful in the 
localization of several HRE [l l-131, DNA fragments 
compete with DNA-cellulose for the binding of the 
labelled receptor. As shown in Fig.2A, fragment c 
(- 613/ + 437) was the most effective in the binding 
displacement. To delimit more precisely the binding 
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Fig. 1. Schematic structure of the pUG5 clone. The black box represents the first exon. The numbering starts at the initiation site (arrow). The 
striped circle indicates the glucocorticoid/progesterone receptor binding site previously described [8]. The empty circle denotes the ER binding site 
observed in this study. Also shown are the restriction sites used to generate the fragments indicated by small letters. 
site, smaller subfragments around this zone were prob- 
ed (Fig.2B). The fragment f (-396/+8) strongly 
displaced the binding of the ER to DNA-cellulose. 
Since the consensus equence stablished for the es- 
trogen HRE is the palindrome 5 ‘-aGGTCAnnnTGACC- 
t-3 ’ [2,13], we looked for similar sequences along the 
entire pUG5 DNA. A computer-based search indicated 
the existence of only two possibilities. The first one 
(CGGACAcggAGTCCt) was located at - 2671/ - 2657, 
partially overlapping with the glucocorticoid/pro- 
gesterone HRE detected previously ([8] and Fig. 1). The 
second one (aGGTCAccaTGCCCt) was located at 
-266/-252, i.e. within fragment f. In the light of 
these findings, we obtained double-stranded synthetic 
oligonucleotides of either sequence and tested them in 
the competition assay (Fig.3). The first sequence was 
unable to displace the ER whereas the second oligonu- 
cleotide was shown to be very effective. 
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Fig.2. Competitive binding of uteroglobin genomic fragments to the 
estrogen receptor bound to DNA-cellulose. The percentage of labelled 
receptor bound to DNA-cellulose (100% in the absence of com- 
petitor) was plotted against increasing amounts of competing DNA. 
In A, the fragments used were: - 3255/- 1835 (a); - 1834/- 614 (b); 
-613/+437 (c); +438/+ 1754 (d). In B, the fragments were: 
- 613/- 397 (e); - 396/+ 8 (f); + 9/ + 1044 (g); + 1045/ + 1754 (h). 
4. DISCUSSION 
In this work we present for the first time evidence for 
an ER binding site in the uteroglobin gene. The nu- 
cleotide sequence of this site appears to be the imperfect 
palindrome aGGTCAccaTGCCCt, differing only by 
one nucleotide (position 11) from the canonical consen- 
sus sequence [2,13] or from a functional HRE of the hu- 
man pS2 gene [14]. The interaction of this sequence 
with the ER appears to be selective. No binding of the 
ER was observed with the glucocorticoid/progesterone 
receptor binding site of the uteroglobin gene. The re- 
ceptor does not interact with other similar palindromic 
sequences (- 2671/- 2657) detected by the computer 
search. Weak interactions observed in the binding assay 
with some fragments (Fig.2) might be due to the pres- 
ence of several GGTCA half-palindromic motifs inter- 
spersed throughout the uteroglobin gene. This motif is 
a functional HRE in the ovalbumin gene [ 151 and could 
interact, albeit weakly, with the ER. 
The ER binding element of the uteroglobin gene is 
located in the promoter zone in contrast to the gluco- 
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Fig.3. Competitive binding of synthetic oligonucleotides to the ER. 
The structures of the oligonucleotide upper strands were 5’-CGGAC- 
ACGAGTCCT-3 ’ (1) and 5 ‘-AGGTCACCATGCCCT-3 ’ (2). Condi- 
tions were as in Fig.2. 
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corticoid/progesterone binding sites which lay far up- 
stream from the initiation site [8]. The localization of 
HREs on many different genes is quite variable [ 1,2], 
but the different HREs of the multihormonally regulat- 
ed mouse mammary tumor virus are clustered or even 
overlapping [ 1,2]. It is possible that the different locali- 
zations of the HREs in the uteroglobin gene may play 
some role in the tissue-specific regulation of this gene. 
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